Key Studies in Hematologic Malignancies: Independent Conference Coverage of the 2021 ASCO Scientific Meeting

In this module, Ian W. Flinn, MD, PhD; Shaji Kumar, MD; and Eunice S. Wang, MD, offer an overview of key studies on hematologic malignancies presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. The studies focus on hematologic malignancies, including novel therapies and long-term updates of key clinical trials.

First, Shaji Kumar, MD, will discuss key studies on the care of patients with multiple myeloma (MM). Eunice S. Wang, MD, will then explore top studies related to the care of patients with leukemias. Lastly, Ian W. Flinn, MD, PhD, will review the most clinically relevant studies in chronic lymphocytic leukemia (CLL) and other lymphomas.

The key points discussed in this module are illustrated with thumbnails from the accompanying downloadable PowerPoint slidesets, which can be found here or downloaded by clicking any of the slide thumbnails in the module alongside the expert commentary.

Clinical Care Options plans to measure the educational impact of this activity. Several questions will be asked twice: once at the beginning of the activity and then once again after the discussion that informs the best choice. Your responses will be aggregated for analysis, and your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following questions.